# Integra Lifesciences Holdings Corp: Form 8-K, filed Jun 9, 2025

- Company: [Integra Lifesciences Holdings Corp](/companies/iart.md) (CIK 917520)
- Form: 8-K
- Filed: 2025-06-09
- Accepted by EDGAR: Jun 9, 2025, 06:30 ET
- Period: 2025-06-06
- Accession: 0000917520-25-000060
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/917520/000091752025000060/iart-20250606.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/917520/000091752025000060/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/917520/000091752025000060/iart-20250606.htm

Filed Jun 9, 2025.
Source: SEC EDGAR, the filing index for accession 0000917520-25-000060. Last ingested by Listed: Nov 11, 2026, 00:10 ET. No prices; not investment advice.
